A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M.
Deschasaux M, et al. Among authors: galan p.
Br J Nutr. 2016 Jan 28;115(2):305-14. doi: 10.1017/S0007114515004353. Epub 2015 Nov 16.
Br J Nutr. 2016.
PMID: 26568368
Clinical Trial.